These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26413812)

  • 21. Protein tyrosine phosphatase receptor type γ is a JAK phosphatase and negatively regulates leukocyte integrin activation.
    Mirenda M; Toffali L; Montresor A; Scardoni G; Sorio C; Laudanna C
    J Immunol; 2015 Mar; 194(5):2168-79. PubMed ID: 25624455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.
    Kashyap MK; Amaya-Chanaga CI; Kumar D; Simmons B; Huser N; Gu Y; Hallin M; Lindquist K; Yafawi R; Choi MY; Amine AA; Rassenti LZ; Zhang C; Liu SH; Smeal T; Fantin VR; Kipps TJ; Pernasetti F; Castro JE
    J Hematol Oncol; 2017 May; 10(1):112. PubMed ID: 28526063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease.
    Barretina J; Juncà J; Llano A; Gutiérrez A; Flores A; Blanco J; Clotet B; Esté JA
    Ann Hematol; 2003 Aug; 82(8):500-505. PubMed ID: 12783211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia.
    de Rooij MF; Kuil A; Geest CR; Eldering E; Chang BY; Buggy JJ; Pals ST; Spaargaren M
    Blood; 2012 Mar; 119(11):2590-4. PubMed ID: 22279054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.
    Haerzschel A; Catusse J; Hutterer E; Paunovic M; Zirlik K; Eibel H; Krenn PW; Hartmann TN; Burger M
    Ann Hematol; 2016 Dec; 95(12):1979-1988. PubMed ID: 27542958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell motility in chronic lymphocytic leukemia: defective Rap1 and alphaLbeta2 activation by chemokine.
    Till KJ; Harris RJ; Linford A; Spiller DG; Zuzel M; Cawley JC
    Cancer Res; 2008 Oct; 68(20):8429-36. PubMed ID: 18922916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells.
    Rozovski U; Wu JY; Harris DM; Liu Z; Li P; Hazan-Halevy I; Ferrajoli A; Burger JA; O'Brien S; Jain N; Verstovsek S; Wierda WG; Keating MJ; Estrov Z
    Blood; 2014 Jun; 123(24):3797-802. PubMed ID: 24778152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H-Ras signals to cytoskeletal machinery in induction of integrin-mediated adhesion of T cells.
    Tanaka Y; Minami Y; Mine S; Hirano H; Hu CD; Fujimoto H; Fujii K; Saito K; Tsukada J; van Kooyk Y; Figdor CG; Kataoka T; Eto S
    J Immunol; 1999 Dec; 163(11):6209-16. PubMed ID: 10570313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells.
    Vaisitti T; Aydin S; Rossi D; Cottino F; Bergui L; D'Arena G; Bonello L; Horenstein AL; Brennan P; Pepper C; Gaidano G; Malavasi F; Deaglio S
    Leukemia; 2010 May; 24(5):958-69. PubMed ID: 20220774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of chemokines and their receptors in chronic lymphocytic leukemia: function in microenvironment and targeted therapy.
    Han TT; Fan L; Li JY; Xu W
    Cancer Biol Ther; 2014 Jan; 15(1):3-9. PubMed ID: 24149438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a.
    Ticchioni M; Essafi M; Jeandel PY; Davi F; Cassuto JP; Deckert M; Bernard A
    Oncogene; 2007 Nov; 26(50):7081-91. PubMed ID: 17496928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CLL, but not normal, B cells are dependent on autocrine VEGF and alpha4beta1 integrin for chemokine-induced motility on and through endothelium.
    Till KJ; Spiller DG; Harris RJ; Chen H; Zuzel M; Cawley JC
    Blood; 2005 Jun; 105(12):4813-9. PubMed ID: 15731179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.
    Baudot AD; Jeandel PY; Mouska X; Maurer U; Tartare-Deckert S; Raynaud SD; Cassuto JP; Ticchioni M; Deckert M
    Oncogene; 2009 Sep; 28(37):3261-73. PubMed ID: 19581935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stroma.
    Plander M; Ugocsai P; Seegers S; Orsó E; Reichle A; Schmitz G; Hofstädter F; Brockhoff G
    Ann Hematol; 2011 Dec; 90(12):1381-90. PubMed ID: 21465189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia.
    Benkisser-Petersen M; Buchner M; Dörffel A; Dühren-von-Minden M; Claus R; Kläsener K; Leberecht K; Burger M; Dierks C; Jumaa H; Malavasi F; Reth M; Veelken H; Duyster J; Zirlik K
    PLoS One; 2016; 11(12):e0169159. PubMed ID: 28036404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation.
    Edelmann B; Gupta N; Schnoeder TM; Oelschlegel AM; Shahzad K; Goldschmidt J; Philipsen L; Weinert S; Ghosh A; Saalfeld FC; Nimmagadda SC; Müller P; Braun-Dullaeus R; Mohr J; Wolleschak D; Kliche S; Amthauer H; Heidel FH; Schraven B; Isermann B; Müller AJ; Fischer T
    J Clin Invest; 2018 Oct; 128(10):4359-4371. PubMed ID: 30024857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia.
    Giannoni P; Cutrona G; Totero D
    Curr Mol Med; 2017; 17(1):24-33. PubMed ID: 28231754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells.
    Glodek AM; Le Y; Dykxhoorn DM; Park SY; Mostoslavsky G; Mulligan R; Lieberman J; Beggs HE; Honczarenko M; Silberstein LE
    Leukemia; 2007 Aug; 21(8):1723-32. PubMed ID: 17568820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease.
    Vlad A; Deglesne PA; Letestu R; Saint-Georges S; Chevallier N; Baran-Marszak F; Varin-Blank N; Ajchenbaum-Cymbalista F; Ledoux D
    Cancer Res; 2009 Aug; 69(16):6387-95. PubMed ID: 19654311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406.
    Borge M; Remes Lenicov F; Nannini PR; de los Ríos Alicandú MM; Podaza E; Ceballos A; Fernández Grecco H; Cabrejo M; Bezares RF; Morande PE; Oppezzo P; Giordano M; Gamberale R
    J Immunol; 2014 Sep; 193(6):3165-74. PubMed ID: 25127862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.